Peking University Third Hospital

This study is testing whether a new herbal ointment called Xiang Lei can help heal diabetic foot ulcers faster and more effectively. Researchers will enroll 56 adults with diabetes who have non-healing ulcers to compare the ointment against standard care. The goal is to see if th…

This study is testing if waiting an extra 1-2 days to give the final 'trigger' shot during IVF leads to better results. Researchers will compare the standard timing to a delayed timing in about 834 women undergoing IVF to see which method creates more high-quality embryos and lea…

This study is comparing two antiviral medications, Brivudine and Famciclovir, to see which one works better for treating shingles. It will involve 140 adults with active shingles and will measure how well each drug reduces pain and helps the rash heal. The main goal is to see whi…

This study is testing whether a wearable device that guides exercises at home can help people recover shoulder movement and strength after rotator cuff surgery. It will compare this remote approach to traditional in-person physical therapy. The goal is to see if the device is a s…

This study is testing a combination of three drugs (pomalidomide, orelabrutinib, and zuberitamab) in people newly diagnosed with mantle cell lymphoma, a type of blood cancer. The main goal is to see how well this combination clears the body of tiny amounts of leftover cancer cell…

This study aims to understand what makes a topical cream called ruxolitinib more or less effective for people with vitiligo, a condition that causes white patches on the skin. Researchers will follow 170 patients in a real-world setting for 24 weeks to see which patient character…

This study compares two less-invasive heart bypass surgery methods for patients with severe coronary artery disease. Researchers want to see if a new 'no-touch' technique, which avoids handling a major artery in the chest, is as safe and effective as a standard minimally invasive…

This study is testing a new type of antibacterial, absorbable dressing to see if it can help heal chronic wounds that have not improved for at least a week. Researchers will measure how much the wound size shrinks over three weeks and check for any side effects. The goal is to pr…

This study is testing whether adding a drug called tetrandrine to standard treatment can better control lung scarring in adults with connective tissue disease-related interstitial lung disease. About 100 participants will take either tetrandrine or a placebo pill for 24 weeks whi…

This study is testing whether a combination of two drugs, glofitamab and lenalidomide, can help control a hard-to-treat type of blood cancer called mantle cell lymphoma. It is for patients whose cancer has come back or stopped responding to previous treatments, including a specif…

This study is testing a new type of balance training that uses visual guidance to help people recover after ACL knee surgery. It will compare this new training to standard rehabilitation exercises to see if it improves knee strength, walking patterns, and confidence in movement. …

This study is testing a medication called Teprotumumab N01 for people with active Thyroid Eye Disease (TED), a condition that causes eye bulging, double vision, and swelling. Fifty participants will receive the drug and have their eye symptoms and quality of life tracked for 24 w…

This study is testing a new, more detailed ultrasound technology to help doctors better tell if a swollen lymph node is cancerous or benign. It will involve 779 adults with suspicious lymph nodes who are already scheduled for a biopsy or surgery. The goal is to see if this advanc…

This study is comparing two ways to help people recover from a frozen shoulder. It will test a new smart wearable device that guides exercises at home against traditional in-person physical therapy. Researchers want to see which method is better at reducing pain and improving sho…

This study aims to learn more about people with rheumatoid arthritis (RA) that doesn't respond well to standard treatments, known as 'refractory RA.' Researchers will follow 200 adults with this condition over time to observe their symptoms, immune system patterns, and quality of…

This study aims to understand what factors predict future heart attacks, strokes, and other serious complications in people with cardiovascular-kidney-metabolic (CKM) syndrome. Researchers will follow over 4500 patients for at least three years, collecting detailed health data an…